Enzalutamide before Abiraterone - Advanced Prostate...

Advanced Prostate Cancer

21,849 members27,367 posts

Enzalutamide before Abiraterone

Ausi profile image
Ausi
2 Replies

jamanetwork.com/journals/ja...

A recent study concludes that Enzalutamide is slightly more beneficial if used before Abiraterone. This is contrary to other studies which some of you have posted recently.

“Findings In this cohort study of 5779 patients with mCRPC from the US Department of Veterans Affairs health care system from 2014 to 2022, initiation of enzalutamide was associated with small but statistically significant improvements in survival times compared with initiation of abiraterone acetate, with more prominent improvements in short-term outcomes and in patient subgroups with less aggressive prostate cancer.”

Written by
Ausi profile image
Ausi
To view profiles and participate in discussions please or .
Read more about...
2 Replies
TeleGuy profile image
TeleGuy

I quickly skimmed it and looked at the flowchart, and my understanding is they didn’t look at the efficacy of enza then abi vs abi then enza. They just looked at metrics for treatment with one or the other.

Rocketman1960 profile image
Rocketman1960

I will add my data point of 1. On Xtandi 66 months when it failed. MO says maybe 10% chance Zytiga would work. Have been on Zytiga + prednisone for 6 months with 4 PSA drops in a row. Its working and for that I am Eternally grateful for the Providence given to me.

Not what you're looking for?

You may also like...

Abiraterone vs Enzalutamide + Radiation

I would like to solicit the valued opinion of members of the HU community regarding the potential...

BAT & Abiraterone / Enzalutamide resensitization

BAT is bipolar androgen therapy. Men receive cyclic high-dose testosterone injections while on...

Abiraterone [Zytiga] or Enzalutamide [Xtandi]?

Abi or Enza? For men with cardiovascular issues or hypertension, a new study [1] might influence...

Abiraterone or Enzalutamide in Advanced CRPC.

New study below. "We found weak evidence that enzalutamide {Xtandi} outperforms AA {abiraterone...

Abiraterone and Enzalutamide Raise Metabolic, Cardiovascular Adverse Event Risks

Abiraterone was significantly associated with an 84% and 37% increased risk for a major or minor...